Day One Biopharmaceuticals Inc (DAWN)

Other Income/Expenses (Net)

$4.20M

Quarterly · Period ending: · USD

DAWN logo

DAWN Other Income/Expenses (Net)

Latest reported$4.20M
DAWN Quarterly Other Income/Expenses (Net) (-$223.00K → $4.20M)
High-resolution chart · PNG

DAWN other income/expenses (net) history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Day One Biopharmaceuticals Inc Other Income/Expenses (Net) — Quarterly (USD)
Period endingOther Income/Expenses (Net) (USD)
4,204,000
4,525,000
4,652,000
5,071,000
6,092,000
6,519,000
111,952,000
4,355,000
5,006,000
5,288,000
3,391,000
3,462,000
2,634,000
1,904,000
189,000
1,000
37,000
1,000
-34,000
-15,000
-29,456,000
-281,000
-100,000
-223,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.